Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
出版年份 2021 全文链接
标题
Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-18
DOI
10.3389/fphar.2021.720474
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non‐small cell lung cancer cells
- (2020) Qinquan Tan et al. ENVIRONMENTAL TOXICOLOGY
- Ginsenoside Rg3 suppresses the growth of gemcitabine‐resistant pancreatic cancer cells by upregulating lncRNA‐CASC2 and activating PTEN signaling
- (2020) Jifeng Zou et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway
- (2020) Un-Jung Yun et al. Cancers
- Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines
- (2020) Ga-Young Lee et al. Chinese Journal of Integrative Medicine
- Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
- (2020) Panpan Wang et al. PeerJ
- Interactions of the major effective components in Shengmai formula with breast cancer resistance protein at the cellular and vesicular levels
- (2020) Lingna Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- 20(S)-ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to icotinib through inhibition of autophagy
- (2019) Xiao-Ju Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Reversal effect of ginsenoside Rh2 on oxaliplatin‑resistant colon cancer cells and its mechanism
- (2019) Jun Ma et al. Experimental and Therapeutic Medicine
- Ginsenoside Rk1 induces cell death through ROS-mediated PTEN/PI3K/Akt/mTOR signaling pathway in MCF-7 cells
- (2019) Yinan Hong et al. Journal of Functional Foods
- Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial–mesenchymal transition and stemness
- (2018) Jingjing Wang et al. CANCER LETTERS
- Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors
- (2018) Chao Liu et al. Oncology Letters
- The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism
- (2018) Gui-wei Liu et al. Human Cell
- Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
- (2018) Sen-Ling Feng et al. Journal of Ginseng Research
- Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
- (2017) Saikat Dewanjee et al. MOLECULES
- Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
- (2017) Jian Yuan Goh et al. NATURE MEDICINE
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
- (2016) Safiulla Basha Syed et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function
- (2016) Gang Chen et al. Oncotarget
- Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
- (2016) Yan Li et al. Oncotarget
- Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomes
- (2015) Wang Gang et al. International Journal of Nanomedicine
- 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin
- (2015) Dong-Gun Kim et al. Oncotarget
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Ginseng and Anticancer Drug Combination to Improve Cancer Chemotherapy: A Critical Review
- (2014) Shihong Chen et al. Evidence-based Complementary and Alternative Medicine
- Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition
- (2013) Un-Jung Yun et al. BIOCHEMICAL PHARMACOLOGY
- Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
- (2013) Ramya Vadlapatla et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
- (2013) B Mao et al. ONCOGENE
- Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response
- (2013) Matthew David Hale et al. CELLULAR ONCOLOGY
- Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
- (2012) Jean-Philippe Cosse et al. Anti-Cancer Agents in Medicinal Chemistry
- Overview of P-glycoprotein inhibitors: a rational outlook
- (2012) Kale Mohana Raghava Srivalli et al. Brazilian Journal of Pharmaceutical Sciences
- Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
- (2012) Ruby Yun-Ju Huang et al. CURRENT DRUG TARGETS
- SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells
- (2012) Z Wang et al. ONCOGENE
- Stereoselective Regulations of P-Glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics
- (2012) Jingwei Zhang et al. PLoS One
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells
- (2011) Jingwei Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The dual role of autophagy in cancer
- (2011) Eeva-Liisa Eskelinen CURRENT OPINION IN PHARMACOLOGY
- Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein
- (2011) Zsolt Bikadi et al. PLoS One
- A dynamic study on reversal of multidrug resistance by ginsenoside Rh2 in adriamycin-resistant human breast cancer MCF-7 cells
- (2011) Bei Zhou et al. TALANTA
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
- (2010) R. J. Kelly et al. CLINICAL CANCER RESEARCH
- 20(S)-Ginsenoside Rh2 Noncompetitively Inhibits P-Glycoprotein In Vitro and In Vivo: A Case for Herb-Drug Interactions
- (2010) J. Zhang et al. DRUG METABOLISM AND DISPOSITION
- Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB
- (2010) Sun Mi Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Increased Ubiquitination of Multidrug Resistance 1 by Ginsenoside Rd
- (2010) Yuba Raj Pokharel∗ et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
- (2010) Chung-Pu Wu et al. Current Molecular Pharmacology
- Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel
- (2009) Sun Mi Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
- (2009) T. Wilson et al. CURRENT CANCER DRUG TARGETS
- 20S-Protopanaxadiol Inhibits P-Glycoprotein in Multidrug Resistant Cancer Cells
- (2009) Yan Zhao et al. PLANTA MEDICA
- Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation
- (2008) Hyog-Young Kwon et al. ARCHIVES OF PHARMACAL RESEARCH
- The epidermal growth factor receptor family: Biology driving targeted therapeutics
- (2008) M. J. Wieduwilt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease
- (2008) Valerie I. Brown et al. IMMUNOLOGIC RESEARCH
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started